Supriya Lifescience expects to double revenue to Rs 1,000 crore in next 3 years

Supriya Lifescience aims to double revenue to Rs 1,000 crore by venturing into higher-margin niche segments. Led by Satish Wagh, it is expanding its product basket, diversifying into contract manufacturing, and targeting regulated markets through R&D and filings for new products.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/F8UT9Cp
via IFTTT